Learn more
Log in
0 followers
EnBiotix is a late clinical-stage rare disease company currently focused on therapies for cystic fibrosis, non-CF bronchiectasis, and non-tuberculosis mycobacterial infections, a $15 billion global market.
Industries
Headquarters
Stage
Employees
Links
Jeffrey Wager
4 members
Bristol-Myers Squibb
151 followers
Walgreens Boots Alliance
98 followers
Viatris
25 followers
Syneos Health
12 followers
Parexel
3 followers
Discover companies